<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Advanced <z:hpo ids='HP_0001635'>heart failure</z:hpo> (HF) is associated with severe <z:e sem="disease" ids="C0037315" disease_type="Disease or Syndrome" abbrv="">sleep-disordered breathing</z:e> (SDB) </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, most patients with HF are treated with an implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) for primary prevention of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy in such a patient cohort with SDB has never been investigated </plain></SENT>
<SENT sid="3" pm="."><plain>The present study sought to determine the effect of SDB on the incidence of appropriate and inappropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy in patients with a categorical primary prevention <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> indication </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 133 consecutive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients with New York Heart Association class II-III HF and depressed left ventricular function (≤35%) with no history of <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> underwent a sleep study before <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation and were followed for 24 ± 8 months, prospectively </plain></SENT>
<SENT sid="5" pm="."><plain>A relevant SDB was defined as an <z:hpo ids='HP_0002104'>apnea</z:hpo>-<z:mp ids='MP_0001956'>hypopnea</z:mp> index of ≥10 events/hour </plain></SENT>
<SENT sid="6" pm="."><plain>Of these 133 patients, 82 (62%) had SDB </plain></SENT>
<SENT sid="7" pm="."><plain>Overweight (body mass index &gt;29.1 vs 24.7 kg/m(2); p &lt;0.001) was identified as the only independent risk factor for SDB </plain></SENT>
<SENT sid="8" pm="."><plain>Appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy intervention was significantly greater among patients with SDB than among patients without SDB (54% vs 34%, p = 0.03) </plain></SENT>
<SENT sid="9" pm="."><plain>Inappropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy intervention was documented more often in patients with SDB (n = 24 [29%] vs 7 [14%]; p = 0.04) </plain></SENT>
<SENT sid="10" pm="."><plain>An <z:hpo ids='HP_0002104'>apnea</z:hpo>-<z:mp ids='MP_0001956'>hypopnea</z:mp> index &gt;10 events/hour was an independent predictor of appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy on multivariate analysis (odds ratio 2.5, 95% confidence interval 1.8 to 4.04; p = 0.01) </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, the present study is the first trial exploring the effect of SDB on the incidence of appropriate and inappropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy in patients with HF with a primary prevention indication </plain></SENT>
<SENT sid="12" pm="."><plain>These results indicate that a preimplantation sleep study will identify patients with HF prone to receive appropriate and inappropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy </plain></SENT>
</text></document>